{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:56:56Z","timestamp":1786985816870,"version":"build-2736575974"},"reference-count":20,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100020410","name":"T\u00fcrkiye Sa\u011fl\u0131k Enstit\u00fcleri Ba\u015fkanl\u0131\u011f\u0131","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020410","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.cca.2024.117793","type":"journal-article","created":{"date-parts":[[2024,2,2]],"date-time":"2024-02-02T00:43:11Z","timestamp":1706834591000},"page":"117793","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Validation of SMA screening kits with SMN1 gene analysis in a Turkish cohort"],"prefix":"10.1016","volume":"555","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4494-9536","authenticated-orcid":false,"given":"Murat","family":"G\u00fcl\u015fen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmet Cevdet","family":"Ceylan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taha","family":"Bahsi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hikmet Can","family":"\u00c7ubuk\u00e7u","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Onur Burak","family":"Dursun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.cca.2024.117793_b0005","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1002\/ajmg.a.61124","article-title":"The burden of rare diseases","volume":"179","author":"Ferreira","year":"2019","journal-title":"Am. J. Med. Genet. A"},{"key":"10.1016\/j.cca.2024.117793_b0010","first-page":"127","article-title":"Biotinidase deficiency: prevalence, impact and management strategies","volume":"11","author":"Canda","year":"2020","journal-title":"Pediatric Health, Medicine and Therapeutics."},{"key":"10.1016\/j.cca.2024.117793_b0015","doi-asserted-by":"crossref","unstructured":"Castellani C, Massie J, Sontag M, Southern KW. Newborn screening for cystic fibrosis. The Lancet Respiratory Medicine [Internet]. 2016;4(8):653\u201361. Available from: http:\/\/dx.doi.org\/10.1016\/S2213-2600(16)00053-9.","DOI":"10.1016\/S2213-2600(16)00053-9"},{"key":"10.1016\/j.cca.2024.117793_b0020","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jpeds.2022.10.046","article-title":"Cost-effectiveness of newborn screening for phenylketonuria and congenital hypothyroidism","volume":"256","author":"Appelberg","year":"2023","journal-title":"J. Pediatr."},{"key":"10.1016\/j.cca.2024.117793_b0025","doi-asserted-by":"crossref","unstructured":"Munsat TL, Davies KE. International SMA consortium meeting. (26-28 June 1992, Bonn, Germany). Vol. 2, Neuromuscular disorders\u00a0: NMD. Bonn, Germany; 1992. p. 423\u20138.","DOI":"10.1016\/S0960-8966(06)80015-5"},{"key":"10.1016\/j.cca.2024.117793_b0030","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1001\/archneur.1995.00540290108025","article-title":"Natural history in proximal spinal muscular atrophy clinical analysis of 445 patients and suggestions for a modification of existing classifications ist to predict the course of SMA in a single","volume":"52","author":"Zerres","year":"1995","journal-title":"Arch. Neurol."},{"issue":"6","key":"10.1016\/j.cca.2024.117793_b0035","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/s00439-002-0828-x","article-title":"Genetic testing and risk assessment for spinal muscular atrophy (SMA)","volume":"111","author":"Ogino","year":"2002","journal-title":"Hum. Genet."},{"issue":"10","key":"10.1016\/j.cca.2024.117793_b0040","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1212\/WNL.0000000000002445","article-title":"Results from a phase 1 study of nusinersen (ISIS-SMN Rx) in children with spinal muscular atrophy","volume":"86","author":"Chiriboga","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.cca.2024.117793_b0045","doi-asserted-by":"crossref","unstructured":"Finkel RS, Mercuri E, Meyer OH, Simonds AK, Schroth MK, Graham RJ, et al. Diagnosis and management of spinal muscular atrophy: Part 2: Pulmonary and acute care; medications, supplements and immunizations; other organ systems; and ethics. Neuromuscular Disorders [Internet]. 2018;28(3):197\u2013207. Available from: https:\/\/doi.org\/10.1016\/j.nmd.2017.11.004.","DOI":"10.1016\/j.nmd.2017.11.004"},{"issue":"4","key":"10.1016\/j.cca.2024.117793_b0050","doi-asserted-by":"crossref","first-page":"503","DOI":"10.3233\/JND-190428","article-title":"One year of newborn screening for SMA \u2013 Results of a German pilot project","volume":"6","author":"Vill","year":"2019","journal-title":"Journal of Neuromuscular Diseases"},{"issue":"6","key":"10.1016\/j.cca.2024.117793_b0055","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.nmd.2021.03.007","article-title":"Newborn screening programs for spinal muscular atrophy worldwide: where we stand and where to go","volume":"31","author":"Dangouloff","year":"2021","journal-title":"Neuromuscul. Disord."},{"issue":"11","key":"10.1016\/j.cca.2024.117793_b0060","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1097\/GIM.0b013e318188d069","article-title":"Carrier screening for spinal muscular atrophy","volume":"10","author":"Prior","year":"2008","journal-title":"Genet. Med."},{"issue":"3","key":"10.1016\/j.cca.2024.117793_b0065","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1002\/(SICI)1098-1004(200003)15:3<228::AID-HUMU3>3.0.CO;2-9","article-title":"An update of the mutation spectrum of the survival motor neuron gene (SMN1) in autosomal recessive spinal muscular atrophy (SMA)","volume":"15","author":"Wirth","year":"2000","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.cca.2024.117793_b0070","doi-asserted-by":"crossref","unstructured":"Wirth B, Brichta L, Schrank B, Lochm\u00fcller H, Blick S, Baasner A, et al. Mildly affected patients with spinal muscular atrophy are partially protected by an increased SMN2 copy number. Human genetics [Internet]. 2006 May 1;119(4):422\u20138. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16508748.","DOI":"10.1007\/s00439-006-0156-7"},{"key":"10.1016\/j.cca.2024.117793_b0075","doi-asserted-by":"crossref","unstructured":"Simoens S, Huys I. Market access of Spinraza (Nusinersen) for spinal muscular atrophy: Intellectual property rights, pricing, value and coverage considerations. Gene Therapy [Internet]. 2017;24(9):539\u201341. Available from: http:\/\/dx.doi.org\/10.1038\/gt.2017.79.","DOI":"10.1038\/gt.2017.79"},{"issue":"02","key":"10.1016\/j.cca.2024.117793_b0080","doi-asserted-by":"crossref","first-page":"111","DOI":"10.4236\/ojgen.2013.32014","article-title":"1000 sample comparison of MLPA and RT-PCR for carrier detection and diagnostic testing for spinal muscular atrophy type 1","volume":"03","author":"Strom","year":"2013","journal-title":"Open Journal of Genetics."},{"key":"10.1016\/j.cca.2024.117793_b0085","doi-asserted-by":"crossref","unstructured":"Ar Rochmah M, Awano H, Awaya T, Harahap NIF, Morisada N, Bouike Y, et al. Spinal muscular atrophy carriers with two SMN1 copies. Brain and Development [Internet]. 2017;39(10):851\u201360. Available from: http:\/\/dx.doi.org\/10.1016\/j.braindev.2017.06.002.","DOI":"10.1016\/j.braindev.2017.06.002"},{"issue":"5","key":"10.1016\/j.cca.2024.117793_b0090","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1002\/ana.20473","article-title":"Natural history of denervation in SMA: relation to age, SMN2 copy number, and function","volume":"57","author":"Swoboda","year":"2005","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.cca.2024.117793_b0095","unstructured":"T.C. Sa\u011fl\u0131k Bakanl\u0131\u011f\u0131 Halk Sa\u011fl\u0131\u011f\u0131 Genel M\u00fcd\u00fcrl\u00fc\u011f\u00fc \u00c7ocuk ve Ergen Sa\u011fl\u0131\u011f\u0131 Dairesi Ba\u015fkanl\u0131\u011f\u0131. Yenido\u011fan Metabolik ve Endokrin Hastal\u0131k Tarama Program\u0131 (NTP) [Internet]. [cited 2023 Nov 22]. Available from: https:\/\/hsgm.saglik.gov.tr\/tr\/tarama-programlari\/ntp.html."},{"key":"10.1016\/j.cca.2024.117793_b0100","unstructured":"T.C. Sa\u011fl\u0131k Bakanl\u0131\u011f\u0131 Halk Sa\u011fl\u0131\u011f\u0131 Genel M\u00fcd\u00fcrl\u00fc\u011f\u00fc \u00c7ocuk ve Ergen Sa\u011fl\u0131\u011f\u0131 Dairesi Ba\u015fkanl\u0131\u011f\u0131. Evlilik \u00d6ncesi Spinal Musk\u00fcler Atrofi (SMA) Ta\u015f\u0131y\u0131c\u0131 Tarama Program\u0131 [Internet]. [cited 2023 Nov 22]. Available from: https:\/\/hsgm.saglik.gov.tr\/tr\/tarama-programlari\/evlilik-oncesi-sma-tasiyici-tarama-programi.html."}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898124000342?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898124000342?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T15:13:14Z","timestamp":1757862794000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898124000342"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":20,"alternative-id":["S0009898124000342"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2024.117793","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Validation of SMA screening kits with SMN1 gene analysis in a Turkish cohort","name":"articletitle","label":"Article Title"},{"value":"Clinica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cca.2024.117793","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"117793"}}